Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer

Kim, Jaihwan; Choi, Il Ju; Kim, Chan Gyoo; Lee, Jong Yeul; Cho, Soo‐Jeong; Park, Sook Ryun; Lee, Jun Ho; Ryu, Keun Won; Kim, Young Woo; Park, Young-Iee

doi:10.1007/s00464-010-1426-y

Cited by 20 publications

(16 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We were concerned about the safe and successful placement of the stent, because limited data are available on the safety of SEMS placement in postgastrectomy patients [13, 14]. Song et al [13] placed SEMSs in 39 patients with malignant anastomotic obstructions after gastrojejunostomy and reported their results.…”

Section: Discussionmentioning

confidence: 99%

“…However, aspiration pneumonia, stent migration, and reobstruction occurred in 2, 4, and 2 patients, respectively, with a total complication rate of 23.1%. Kim et al [14] also reported the results for 39 postgastrectomy patients who underwent SEMS placement. The technical success rate was 92% and the total complication rate was 44%.…”

Section: Discussionmentioning

confidence: 99%

“…The technical success rate was 92% and the total complication rate was 44%. In the series of Kim et al [14], 2 patients suffered from stent-associated perforation. On the basis of previous studies, we infer that SEMS placement is more risky in postgastrectomy patients than in patients with unresectable primary gastric cancers, although the treatment is technically feasible.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

WallFlex™ Duodenal Stent Placement in a Gastric Cancer Patient with Malignant Stenosis of a Roux-en-Y Gastrojejunostomy following Distal Gastrectomy

Kakuta

Yajima

Kayama³

et al. 2012

Case Rep Oncol

View full text Add to dashboard Cite

A 69-year-old Japanese woman with a history of distal gastrectomy with a Roux-en-Y reconstruction for advanced gastric cancer was admitted to our hospital complaining of severe dysphagia. On admission, the patient was only able to take liquids, and a firm, fist-sized tumor was palpable in her left upper abdomen. An endoscopic examination disclosed stenosis of the jejunal limb of the gastrojejunostomy. Abdominal computed tomography revealed that a recurrent tumor, 5.0 cm in diameter, was compressing the jejunal limb of the gastrojejunostomy. A knitted nitinol self-expandable metallic stent (WallFlex™ duodenal stent) was placed endoscopically at the stenotic jejunum from the gastrojejunostomy. The time required for stenting and total endoscopic manipulation was 12 and 35 minutes, respectively. No stent-related complications were observed. The patient could resume oral ingestion 1 day after endoscopic stenting and was discharged on the fifth day after treatment. She survived for 201 days after stenting. She continued oral ingestion for 194 days and stayed at home for 165 days. The WallFlex duodenal stent allows safe endoscopic stenting, even in cases of malignant stenosis of a gastrojejunostomy following distal gastrectomy. This stenting device will extend the indications for endoscopic palliation of gastric cancer patients with gastric outlet stenosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

WallFlex™ Duodenal Stent Placement in a Gastric Cancer Patient with Malignant Stenosis of a Roux-en-Y Gastrojejunostomy following Distal Gastrectomy

Kakuta

Yajima

Kayama³

et al. 2012

Case Rep Oncol

View full text Add to dashboard Cite

show abstract

“…However, aspiration pneumonia, stent migration, and reobstruction occurred in 2, 4, and 2 patients, respectively, with a total complication rate of 23.1%. Kim and coworkers [14] also reported the results for 39 postgastrectomy patients who underwent SEMS placement. The technical success rate was 92% and the total complication rate was 44%.…”

Section: Complications Associated With Stent Placementmentioning

confidence: 99%

“…Few data are available about the use of SEMS for the nonsurgical palliative treatment for recurrent malignant gastric outlet obstruction [3][4][5][6][7][8][9][10][11] . To our knowledge, few studies focused on endoscopic placement of SEMS in the recurrence of anastomotic strictures [11][12][13][14][15] . In this setting, the clinical outcomes and complications might differ according to the surgical technique because of the different anastomotic angle or different anatomical alterations during surgery.…”

Section: Introductionmentioning

confidence: 99%

Clinical outcomes of self-expandable metallic stents in palliation of malignant anastomotic strictures: a single center experience

Raimondo¹,

Sinagra

Facella³

et al. 2015

Abdomen

View full text Add to dashboard Cite

Background: Self-expandable metallic stents (SEMS) are employed as the preferred nonsurgical palliative treatment for gastric outlet obstruction due to malignancies. Metallic stents are often employed to treat malignant anastomotic obstructions after surgical interventions as esophagojejunostomy, gastrojejunostomy and esophagogastrojejunostomy. Methods: This case series reports prospectively the clinical outcomes of SEMS in the palliative care of malignant anastomotic strictures caused by the recurrence of gastric cancer following gastric surgery as oncological curative treatment, in a series of nine consecutive patients, treated between January 2009 and December 2012 in our center. Results: Nine patients (M:F=8:1) were enrolled in the study. The operation was a total gastrectomy with esophagogastrojejunostomy (n=4), subtotal gastrectomy with Billroth-II reconstruction (n=3), and subtotal gastrectomy with esophagogastrostomy (n=2) .The technical success rate was 88.9%, and the clinical success rates was 88,9 %. The reobstruction of the stent, due to the ingrowth of the tumor, occurred in 1 patient (11,1%) within 1 month after stent placement. The migration of the stent occurred after the placement of a covered stent in 1 patient who underwent a subtotal gastrectomy (with Billroth-II reconstruction). A case of partial stent dislodgement was easily treated with the placement of a second stent. The median survival period was 180 days (range, 30-240 days) and the median stent patency was 45 days (range, 30-90 days). Conclusions: Although the number of the patients treated with SEMS results, in this series, almost small to certainly judge the safety and feasibility of SEMS, we believe that the endoscopic insertion of SEMS seems to be a safe, easily feasible, and effective treatment in the palliative care of malignant anastomotic strictures caused by the recurrence of gastric cancer following gastric surgery. The technical and clinical success, and the onset of complications of this procedure are influenced by several factors, such as the type of anastomosis, the technical features of the stent, and the extent of the underlying tumor. RESEARCH ARTICLEAbdomen 2015; 2: e511. doi: 10.14800/Abdomen.511; © 2015 by Dario Raimondo, et al. To cite this article: Dario Raimondo, et al. Clinical outcomes of self-expandable metallic stents in palliation of malignant anastomotic strictures: a single center experience. Abdomen 2015; 2: e511.

show abstract

Endoscopic Stenting for Gastric Outlet Obstruction

Lee

2021

Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy

View full text Add to dashboard Cite

Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer

Abstract: Endoscopic SEMS placement for obstruction due to recurrent cancer after total or subtotal gastrectomy is feasible and provides effective short-term palliation, independent of the type of surgical procedure or stent (covered vs. uncovered) used.

Cited by 20 publications

References 27 publications

WallFlex™ Duodenal Stent Placement in a Gastric Cancer Patient with Malignant Stenosis of a Roux-en-Y Gastrojejunostomy following Distal Gastrectomy

WallFlex™ Duodenal Stent Placement in a Gastric Cancer Patient with Malignant Stenosis of a Roux-en-Y Gastrojejunostomy following Distal Gastrectomy

Clinical outcomes of self-expandable metallic stents in palliation of malignant anastomotic strictures: a single center experience

Endoscopic Stenting for Gastric Outlet Obstruction

Contact Info

Product

Resources

About